Jinyouli

pegylated recombinant human granulocyte colony-stimulating factor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Jinyouli, covering 2017-08-28 to 2017-08-28. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer [Phase 4]

See pricing